Jacobs John C — SEC Form 4 Insider Trading Activity
Summary
Updated Jul 16, 2026
Jacobs John C is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days.
Profile
John C Jacobs is the President and Chief Executive Officer and a Director of Novavax Inc, a publicly traded biotechnology company focused on vaccine development, per SEC filing CIK 0001820836 dated 2026-01-27. The filing indicates he has no reported purchases or sales and confirms his role on the board, signaling his leadership position at the company.
Role
President and CEO, Director
Notability
50/100
Board memberships
Novavax, Inc.
Awards & honors
Leads Novavax as CEO and serves on the board
Oversees strategic direction and governance of a publicly traded biotech company
Guides vaccine development and corporate operations at a clinical-stage company
John C Jacobs is the President and Chief Executive Officer and a Director of Novavax Inc, a publicly traded biotechnology company focused on vaccine development, per SEC filing CIK 0001820836 dated 2026-01-27. The filing indicates he has no reported purchases or sales and confirms his role on the board, signaling his leadership position at the company.…
Where can I see all of Jacobs John C's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
